216 related articles for article (PubMed ID: 19358621)
1. Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies.
Labarère J; Sevestre MA; Belmin J; Legagneux A; Barrellier MT; Thiel H; Le Roux P; Pernod G; Bosson JL;
Drugs Aging; 2009; 26(3):263-71. PubMed ID: 19358621
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a guideline for venous thromboembolism prophylaxis in elderly post-acute care patients: a multicenter study with systematic ultrasonographic examination.
Sellier E; Labarere J; Bosson JL; Auvray M; Barrellier MT; Le Hello C; Belmin J; Le Roux P; Sevestre MA;
Arch Intern Med; 2006 Oct; 166(19):2065-71. PubMed ID: 17060535
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
6. Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.
Merli GJ; Hollander JE; Lefebvre P; Laliberté F; Raut MK; Germain G; Bookhart B; Pollack CV
J Med Econ; 2016; 19(1):84-90. PubMed ID: 26390315
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
8. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
[TBL] [Abstract][Full Text] [Related]
9. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low--molecular weight heparin.
Michot M; Conen D; Holtz D; Erni D; Zumstein MD; Ruflin GB; Renner N
Arthroscopy; 2002 Mar; 18(3):257-63. PubMed ID: 11877611
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
11. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of postoperative deep vein thrombosis (DVT) under low molecular weight heparin (LMWH) prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries.
Wang H; Pei H; Ding W; Yang D; Ma L
J Thromb Thrombolysis; 2021 Feb; 51(2):397-404. PubMed ID: 32562101
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
15. Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study.
Li L; Zhou J; Huang L; Zhen J; Yao L; Xu L; Zhang W; Zhang G; Chen Q; Cheng B; Gong S; Cai G; Jiang R; Yan J;
Ann Med; 2021 Dec; 53(1):2234-2245. PubMed ID: 34797177
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the effectiveness of a deep-vein thrombosis prophylaxis protocol in orthopaedics and traumatology.
Unay K; Akan K; Sener N; Cakir M; Poyanli O
J Eval Clin Pract; 2009 Aug; 15(4):668-74. PubMed ID: 19674218
[TBL] [Abstract][Full Text] [Related]
17. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
18. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials.
Chapelle C; Rosencher N; Jacques Zufferey P; Mismetti P; Cucherat M; Laporte S;
Arthroscopy; 2014 Aug; 30(8):987-96. PubMed ID: 24813323
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin for deep vein thrombosis in glioma patients.
Schmidt F; Faul C; Dichgans J; Weller M
J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality.
Leonardi MJ; McGory ML; Ko CY
Ann Surg Oncol; 2007 Feb; 14(2):929-36. PubMed ID: 17103259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
